Cargando…
Tricyclic antidepressant amitriptyline inhibits 5-hydroxytryptamine 3 receptor currents in NCB-20 cells
Amitriptyline, a tricyclic antidepressant, is commonly used to treat depression and neuropathic pain, but its mechanism is still unclear. We tested the effect of amitriptyline on 5-hydroxytryptamine 3 (5-HT(3)) receptor currents and studied its blocking mechanism because the clinical applications of...
Autores principales: | Park, Yong Soo, Myeong, Seok Ho, Kim, In-Beom, Sung, Ki-Wug |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115347/ https://www.ncbi.nlm.nih.gov/pubmed/30181705 http://dx.doi.org/10.4196/kjpp.2018.22.5.585 |
Ejemplares similares
-
Gastroprokinetic agent, mosapride inhibits 5-HT(3) receptor currents in NCB-20 cells
por: Park, Yong Soo, et al.
Publicado: (2019) -
Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT(3) receptor currents in NCB-20 cells
por: Park, Yong Soo, et al.
Publicado: (2019) -
Lamotrigine, an antiepileptic drug, inhibits 5-HT(3) receptor currents in NCB-20 neuroblastoma cells
por: Kim, Ki Jung, et al.
Publicado: (2017) -
Tricyclic Antidepressants Amitriptyline and Desipramine Induced Neurotoxicity Associated with Parkinson’s Disease
por: Lee, Min-yeong, et al.
Publicado: (2015) -
Calcium-Dependent Interplay of Lithium and Tricyclic Antidepressants, Amitriptyline and Desipramine, on N-methyl-D-aspartate Receptors
por: Boikov, Sergei I., et al.
Publicado: (2022)